These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36989115)

  • 1. Encapsulation and Assessment of Antidiabetic Potential of α-Lactalbumin-Derived Hydrolysates.
    Puri B; Meena S; Kumar M H S; Shelke PA; Sabikhi L; Ashutosh
    J Agric Food Chem; 2023 Apr; 71(14):5547-5553. PubMed ID: 36989115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.
    Green BD; Irwin N; Duffy NA; Gault VA; O'harte FP; Flatt PR
    Eur J Pharmacol; 2006 Oct; 547(1-3):192-9. PubMed ID: 16945366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of zonulin and GLP-1/DPP-IV in alleviation of diabetes mellitus by peptide/polypeptide fraction of Aloe vera in streptozotocin- induced diabetic wistar rats.
    Babu SN; Govindarajan S; Vijayalakshmi MA; Noor A
    J Ethnopharmacol; 2021 May; 272():113949. PubMed ID: 33610707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel long acting DPP-IV inhibitor PKF-275-055 stimulates β-cell proliferation resulting in improved glucose homeostasis in diabetic rats.
    Akarte AS; Srinivasan BP; Gandhi S
    Biochem Pharmacol; 2012 Jan; 83(2):241-52. PubMed ID: 22015634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihyperglycemic effects of ASP8497 in streptozotocin-nicotinamide induced diabetic rats: comparison with other dipeptidyl peptidase-IV inhibitors.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
    Pharmacol Rep; 2009; 61(5):899-908. PubMed ID: 19904014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice.
    Liu X; Harada N; Yamane S; Kitajima L; Uchida S; Hamasaki A; Mukai E; Toyoda K; Yamada C; Yamada Y; Seino Y; Inagaki N
    Life Sci; 2009 Jun; 84(25-26):876-81. PubMed ID: 19358859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antidiabetic drugs on dipeptidyl peptidase IV activity: nateglinide is an inhibitor of DPP IV and augments the antidiabetic activity of glucagon-like peptide-1.
    Duffy NA; Green BD; Irwin N; Gault VA; McKillop AM; O'Harte FP; Flatt PR
    Eur J Pharmacol; 2007 Jul; 568(1-3):278-86. PubMed ID: 17573070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic administration of voglibose, an alpha-glucosidase inhibitor, increases active glucagon-like peptide-1 levels by increasing its secretion and decreasing dipeptidyl peptidase-4 activity in ob/ob mice.
    Moritoh Y; Takeuchi K; Hazama M
    J Pharmacol Exp Ther; 2009 May; 329(2):669-76. PubMed ID: 19208898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of glycemic control in streptozotocin-induced diabetic rats by Atlantic salmon skin gelatin hydrolysate as the dipeptidyl-peptidase IV inhibitor.
    Hsieh CH; Wang TY; Hung CC; Chen MC; Hsu KC
    Food Funct; 2015 Jun; 6(6):1887-92. PubMed ID: 25946069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atlantic salmon (Salmo salar) co-product-derived protein hydrolysates: A source of antidiabetic peptides.
    Harnedy PA; Parthsarathy V; McLaughlin CM; O'Keeffe MB; Allsopp PJ; McSorley EM; O'Harte FPM; FitzGerald RJ
    Food Res Int; 2018 Apr; 106():598-606. PubMed ID: 29579965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretins: their physiology and application in the treatment of diabetes mellitus.
    Tasyurek HM; Altunbas HA; Balci MK; Sanlioglu S
    Diabetes Metab Res Rev; 2014 Jul; 30(5):354-71. PubMed ID: 24989141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the antidiabetic effects of dipeptidyl peptidase-IV inhibitor ASP8497 in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Tahara A; Matsuyama-Yokono A; Nakano R; Someya Y; Hayakawa M; Shibasaki M
    Pharmacology; 2009; 83(3):177-87. PubMed ID: 19176982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.
    Bae EJ
    Arch Pharm Res; 2016 Aug; 39(8):1114-28. PubMed ID: 27502601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
    Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Dipeptidyl Peptidase IV Inhibitory Tea Peptide Improves Pancreatic β-Cell Function and Reduces α-Cell Proliferation in Streptozotocin-Induced Diabetic Mice.
    Lu Y; Lu P; Wang Y; Fang X; Wu J; Wang X
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of mechanisms through which dipeptidyl peptidase-4 inhibitors regulate glycemia].
    Wang JS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):229-33. PubMed ID: 23643015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes.
    Power O; Nongonierma AB; Jakeman P; FitzGerald RJ
    Proc Nutr Soc; 2014 Feb; 73(1):34-46. PubMed ID: 24131508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycemic effect of a chicken feet hydrolysate via the incretin system: DPP-IV-inhibitory activity and GLP-1 release stimulation.
    Casanova-Martí À; Bravo FI; Serrano J; Ardévol A; Pinent M; Muguerza B
    Food Funct; 2019 Jul; 10(7):4062-4070. PubMed ID: 31225553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
    Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
    J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats.
    Akarte AS; Srinivasan BP; Gandhi S; Sole S
    Eur J Pharm Sci; 2012 Sep; 47(2):456-63. PubMed ID: 22800967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.